Eptifibatide Injection
Product Images NDC 55150-220

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 55150-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Kaplan-meier Plot Of Time To Death Or Myocardial Infarction Within 30 Days Of Randomization In The Pursuit Study (Eptifibatide Fig1)

A line graph showing the percent of patients with events over a 30-day period comparing treatment with Eptifibatide versus placebo. The x-axis represents time in days, and the y-axis represents the percentage of patients experiencing events. The solid line represents Eptifibatide, while the dashed line represents placebo, with the placebo group consistently showing higher event rates over time.*

FDA Label Image

Package Label-principal Display Panel (75 mg per 100 mL (0.75 mg / mL))

Label for Eptifibatide Injection 75 mg per 100 mL (0.75 mg/mL) in a 100 mL single-dose vial for intravenous use. The label states it is sterile, non-pyrogenic, and preservative free. Distribution information lists AuroMedics Pharma LLC. The label includes storage instructions and barcodes.*

FDA Label Image

Package Label-principal Display Panel (75 mg per 100 mL (0.75 mg / mL))

Packaging label for Eptifibatide Injection, 75 mg per 100 mL (0.75 mg/mL) in a 100 mL single-dose vial for intravenous use. Distributed by AuroMedics Pharma LLC in East Windsor, NJ, and made in India. The label states sterile, non-pyrogenic, preservative-free, with storage instructions and contents details. The product is for weight-adjusted infusion.*

FDA Label Image

Package Label-principal Display Panel (20 mg per 10 mL (2 mg / mL))

Label for Eptifibatide Injection 20 mg per 10 mL (2 mg/mL) from AuroMedics Pharma LLC. The single-dose vial is for intravenous use only with sterile, non-pyrogenic, preservative-free contents. Storage instructions and manufacturer location are also included, along with an NDC barcode and usage notes.*

FDA Label Image

Package Label-principal Display Panel (20 mg per 10 mL (2 mg / mL))

Packaging label for Eptifibatide Injection 20 mg per 10 mL (2 mg/mL) intravenous single-dose vial. The label indicates it is for weight-adjusted bolus dosing and includes storage instructions and contents details. Distributed by AuroMedics Pharma LLC, the label notes the product is sterile, non-pyrogenic, preservative free, and made in India.*

FDA Label Image

Package Label-principal Display Panel (200 mg per 100 mL (2 mg / mL))

Eptifibatide Injection 200 mg per 100 mL (2 mg/mL) is shown on a single-dose vial label. The sterile, non-pyrogenic, preservative-free vial is for intravenous use only. The label includes storage instructions and distribution details by AuroMedics Pharma LLC, with a barcode and NDC 55150-220-99 visible.*

FDA Label Image

Package Label-principal Display Panel (200 mg per 100 mL (2 mg / mL))

Packaging label for Eptifibatide Injection 200 mg per 100 mL (2 mg/mL) single-dose vial. The label states it is sterile, non-pyrogenic, preservative-free, for intravenous use only, and intended for weight-adjusted infusion. Distributed by AuroMedics Pharma LLC, made in India. Includes storage instructions and discard information. Bar code and NDC 55150-220-99 are visible.*

FDA Label Image

Eptifibatide Chemical Structure (Eptifibatide Str)

Chemical structure of eptifibatide, showing the molecular arrangement of atoms and bonds characteristic of this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.